Snapshot from Aug 23, 2026 at 07:00 UTC. For live data and tracking: View Live
Business market forecast

Digital Pathology Market Growth Forecast

Analysis based on 10 articles · First reported Jun 24, 2026 · Last updated Jul 16, 2026

Sentiment
40
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The digital pathology market is expected to expand significantly, driven by AI and digital transformation in diagnostics. This growth presents opportunities for companies like Danaher, Roche, and Philips, while increasing competition and investment in AI-powered pathology solutions.

Healthcare Diagnostics Pharmaceutical

Multiple market research reports from MarketsandMarkets, MarketGenics, and The Business Research Company project strong growth for the global digital pathology market. MarketsandMarkets forecasts growth from USD 1.58 billion in 2026 to USD 2.86 billion by 2031 at a CAGR of 12.5%. MarketGenics estimates the market at USD 1.2 billion in 2025, reaching USD 3.6 billion by 2035 at an 11.5% CAGR. The Business Research Company projects USD 3.29 billion by 2030 at an 18.3% CAGR. Key drivers include AI integration, whole-slide imaging adoption, cloud-based platforms, and rising cancer prevalence. The oncology segment holds the largest share, and Asia Pacific is the fastest-growing region. Notable developments include Tempus AI's acquisition of Paige AI for $81.25 million in August 2025, PathAI's launch of its Precision Pathology Network in July 2025, and the Roche-PathAI partnership for AI-enabled companion diagnostics.

80 Tempus AI acquired Paige AI
60 PathAI launched
50 Roche partnered with PathAI
priv
Published market forecast reports projecting 12.5% CAGR growth for digital pathology.
Importance 30.0 Sentiment 0.0
priv
Launched Precision Pathology Network; partnered with Roche; key AI pathology player.
Importance 30.0 Sentiment 55.0
stock
Partnered with PathAI for AI-enabled companion diagnostics; key player in digital pathology.
Importance 25.0 Sentiment 45.0
priv
Acquired by Tempus AI for $81.25 million; strengthens AI pathology capabilities.
Importance 25.0 Sentiment 50.0
priv
Acquired Paige AI for $81.25 million to expand AI pathology capabilities.
Importance 25.0 Sentiment 55.0
cnt
Dominant market with advanced healthcare infrastructure and AI adoption.
Importance 20.0 Sentiment 40.0
cnt
Healthy China 2030 plan supports digital pathology adoption; fastest-growing region.
Importance 20.0 Sentiment 40.0
stock
Listed as a top player in digital pathology; benefits from market growth.
Importance 20.0 Sentiment 40.0
stock
Listed as a top player; benefits from market expansion.
Importance 20.0 Sentiment 40.0
priv
Published market forecast report projecting 18.3% CAGR growth for digital pathology.
Importance 20.0 Sentiment 0.0
cnt
Rising healthcare investments drive digital pathology adoption.
Importance 15.0 Sentiment 35.0
cnt
Home to Hamamatsu, Fujifilm, Olympus, Nikon; significant market player.
Importance 15.0 Sentiment 35.0
stock
Listed as a key player in digital pathology.
Importance 15.0 Sentiment 35.0
stock
Listed as a key player; provides imaging components.
Importance 15.0 Sentiment 35.0
stock
Listed as a key player in digital pathology.
Importance 15.0 Sentiment 35.0
+ 46 more entities View on Dashboard
MarketsandMarkets related Roche
MarketsandMarkets related China
Roche related United States
United States strategic rivals China The United States perceives China as a strategic rival, engaging in an economic and technological competition while also
United States related Philips
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.